How Much Does Targeted genomic sequence analysis of 83 or more genes in cell free circulating dna for detection of abnormalities associated with solid organ cancers Cost on Medicare?

Based on the data, CPT 0326U shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.

Costs have increased 3.0% since 2022. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.

This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.